To Control PPHG Spikes in Type-2 Diabetes with CV Risk
Voglibose 0.2 mg & 0.3 mg Prolonged Release Tablets
Voglibose 0.2 mg & 0.3 mg + Metformin (SR) 500 mg Tablets
Control the Spike.. Prevent the Complications
- Statistically significant reduction in PPHG level & HbA1c (p<0.05)
- Inhibits Advanced Glycation End-product (AGE) induces ROS (Reactive Oxygen Species) formation
- Inhibits cardiac remodelling by decreasing myocardial oxidative stress
